Candel Therapeutics
CADL
CADL
114 hedge funds and large institutions have $213M invested in Candel Therapeutics in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
36% more funds holding
Funds holding: 84 → 114 (+30)
16.24% more ownership
Funds ownership: 43.05% → 59.29% (+16%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
114
Holding in Top 10
1
Calls
$2.14M
Puts
$869K
Top Buyers
| 1 | +$34.9M | |
| 2 | +$15.8M | |
| 3 | +$15M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$6.52M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$6.12M |
Top Sellers
| 1 | -$836K | |
| 2 | -$462K | |
| 3 | -$413K | |
| 4 |
Barclays
London,
United Kingdom
|
-$314K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$312K |
